ISPOR Publishes White Paper Focused on Systemic Coherence for Healthcare Decision Making in Europe

Published Jul 21, 2026

Lawrenceville, NJ, USA—July 21, 2026—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that it has released a new white paper, “Achieving Systemic Coherence for Healthcare Decision Making in Europe.”

The findings and recommendations presented in this white paper are an outcome of the ISPOR Strategic Dialogues: European Union Regulator-HTA-Payer Forum held in October 2025. The paper is intended to support both policy development and structured collaboration aligning evidence generation across stakeholders, toward a more coherent and patient-centric evidence ecosystem.

The white paper notes that patient access pathways in the European Union and European Economic Area are impeded by structural fragmentation across regulatory, health technology assessment (HTA), and payer decision making and evidence generation practices. Additionally, it highlights that operating without a shared evidence roadmap leads to misaligned evidence, persistent uncertainty, and systemic delays. The white paper also provides recommendations on priority actions over the next 12-36 months. Recommendations that are outlined in more detail in the paper include proposals to:

  • Strengthen early stakeholder collaboration
  • Differentiate and adapt assessment approaches
  • Make real-world evidence fit for purpose
  • Establish formal governance and communication mechanisms

“ISPOR's unique strength lies in our ability to bring together regulators, HTA bodies, payers, patients, industry, and researchers around a shared evidence agenda,” stated ISPOR CEO Rob Abbott. “As a neutral convener at the critical interface between scientific evidence and health policy, ISPOR is committed to driving the structured, multistakeholder dialogue Europe needs to move from fragmented evidence generation to a truly integrated, patient-centered system. Toward that end, we plan to convene future Strategic Dialogues Forums to deepen the conversation across stakeholders on what is needed for integrated evidence generation”

The white paper, including a download of the full publication, can be found here.

Additional information and resources:
HEOR Explained Website | Top 10 HEOR Trends Report | US Healthcare System Overview | HEOR News Desk

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | X (@ispororg)  |  Bluesky  |  YouTube  |  Facebook  |  Instagram  

Explore Related HEOR by Topic


Related Stories

ISPOR Europe 2026 Plenaries Announced

Sep 30, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Europe 2026 conference. The conference is the leading global event in Europe for health economics and outcomes research (HEOR) and is scheduled for 8-11 November in Vienna, Austria with the theme, “Shaping the Future of Access Through Science and Policy.”

ISPOR and ISPE Publish Joint Real-World Evidence Transparency Position Statement

Sep 29, 2026

Transparency in research enables the public and decision makers to trust the science that underpins real-world evidence (RWE). ISPOR—The Professional Society for Health Economics and Outcomes Research and the International Society for Pharmacoepidemiology (ISPE) have published a joint RWE Transparency Position Statement.

New Study Sheds Light on QALY and Disability Debate

Sep 28, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a study showing no evidence that the use of quality-adjusted life years (QALYs) inherently disadvantages people with disabilities.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×